Ultime news
-
Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer
Lugano, Switzerland, May 19, 2022 – Helsinn Group, a fully... -
Helsinn to present data at upcoming AMMF’s 2022 European Cholangiocarcinoma Conference
Lugano, Switzerland, May 11, 2022 - Helsinn Group... -
Knight Therapeutics and Helsinn Healthcare SA Enter into Exclusive License, Distribution, and Supply Agreement for Akynzeo® and Aloxi®
MONTREAL, Quebec and LUGANO, Switzerland – May 12, 2022 –...
Linkedin